Crinetics Pharmaceuticals, Inc. CRNX
- atumelnant — Congenital Adrenal Hyperplasia Phase 3
- atumelnant — Adrenal Crisis Phase 2
Home › Targets › corticotropin-releasing factor receptor 1
corticotropin-releasing factor receptor 1 (1 companies · 2 programs)
Companies with an active program directed at corticotropin-releasing factor receptor 1.